サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1435022

養殖用ワクチンの市場：タイプ、製品、投与経路、用途、エンドユーザー別-2024-2030年の世界予測

Aquaculture Vaccines Market by Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Product (DNA Vaccines, Inactivated Vaccines), Route of Administration, Application, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
養殖用ワクチンの市場：タイプ、製品、投与経路、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

養殖用ワクチン市場規模は2023年に3億5,489万米ドルと推定され、2024年には3億7,264万米ドルに達し、CAGR 4.82%で2030年には4億9,367万米ドルに達すると予測されます。

養殖用ワクチンの世界市場

主な市場の統計
基準年[2023］ 3億5,489万米ドル
予測年[2024] 3億7,264万米ドル
予測年 [2030] 4億9,367万米ドル
CAGR（%） 4.82%
養殖用ワクチン Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは養殖用ワクチン市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、養殖用ワクチン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-養殖用ワクチン市場の市場規模および予測は？

2-養殖用ワクチン市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-養殖用ワクチン市場における技術動向と規制の枠組みは？

4-養殖用ワクチン市場における主要ベンダーの市場シェアは？

5-養殖用ワクチン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 細菌およびウイルス感染症の有病率の上昇
      • 水生動物由来の食品へのニーズの高まり
      • 抗生物質よりも養殖用ワクチンの採用が増加
    • 抑制要因
      • 複雑なワクチンの進歩プロセス
    • 機会
      • 新しい養殖用ワクチンの進化と開始
      • 養殖用ワクチン開発のための研究開発活動への投資
    • 課題
      • ワクチン承認のための厳格な規制ポリシー
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 養殖用ワクチンの市場：タイプ別

  • DNAワクチン
  • 不活化ワクチン
  • 弱毒化生ワクチン
  • サブユニットワクチン

第7章 養殖用ワクチンの市場：製品別

  • DNAワクチン
  • 不活化ワクチン

第8章 養殖用ワクチンの市場：投与経路別

  • 注入
  • オーラル

第9章 養殖用ワクチンの市場：用途別

  • 細菌性疾患
  • ウイルス性疾患

第10章 養殖用ワクチンの市場：エンドユーザー別

  • 水産養殖場
  • 水産・養殖業

第11章 南北アメリカの養殖用ワクチンの市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域の養殖用ワクチンの市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカの養殖用ワクチンの市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第15章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • AniCon Labor GmbH by SAN Group
    • Elanco
    • Hipra, S.A.
    • Indian Immunologicals Ltd.
    • KBNP, Inc.
    • Kyoto Biken Laboratories, Inc.
    • Merck & Co., Inc.
    • Nisseiken Co., Ltd.
    • Pfizer Inc.
    • Phibro Animal Health Corporation
    • Vaxxinova International BV
    • Virbac S.A.
    • Zoetis Inc.
  • 主要な製品ポートフォリオ

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. AQUACULTURE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. AQUACULTURE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AQUACULTURE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AQUACULTURE VACCINES MARKET DYNAMICS
  • FIGURE 7. AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 10. AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. AQUACULTURE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. AQUACULTURE VACCINES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AQUACULTURE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AQUACULTURE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AQUACULTURE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. AQUACULTURE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AQUACULTURE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AQUACULTURE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. AQUACULTURE VACCINES MARKET SIZE, BY SUB-UNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. AQUACULTURE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AQUACULTURE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 14. AQUACULTURE VACCINES MARKET SIZE, BY INJECTED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AQUACULTURE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AQUACULTURE VACCINES MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AQUACULTURE VACCINES MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AQUACULTURE VACCINES MARKET SIZE, BY AQUACULTURE FARMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AQUACULTURE VACCINES MARKET SIZE, BY FISHERIES & NURSERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES AQUACULTURE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM AQUACULTURE VACCINES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. AQUACULTURE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 232. AQUACULTURE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. AQUACULTURE VACCINES MARKET LICENSE & PRICING
目次
Product Code: MRR-B16853777885

[182 Pages Report] The Aquaculture Vaccines Market size was estimated at USD 354.89 million in 2023 and expected to reach USD 372.64 million in 2024, at a CAGR 4.82% to reach USD 493.67 million by 2030.

Global Aquaculture Vaccines Market

KEY MARKET STATISTICS
Base Year [2023] USD 354.89 million
Estimated Year [2024] USD 372.64 million
Forecast Year [2030] USD 493.67 million
CAGR (%) 4.82%
Aquaculture Vaccines Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aquaculture Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aquaculture Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Aquaculture Vaccines Market, highlighting leading vendors and their innovative profiles. These include AniCon Labor GmbH by SAN Group, Elanco, Hipra, S.A., Indian Immunologicals Ltd., KBNP, Inc., Kyoto Biken Laboratories, Inc., Merck & Co., Inc., Nisseiken Co., Ltd., Pfizer Inc., Phibro Animal Health Corporation, Vaxxinova International BV, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Aquaculture Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • DNA Vaccines
    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Sub-Unit Vaccines
  • Product
    • DNA Vaccines
    • Inactivated Vaccines
  • Route of Administration
    • Injected
    • Oral
  • Application
    • Bacterial Diseases
    • Viral Diseases
  • End-User
    • Aquaculture Farms
    • Fisheries & Nurseries
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Aquaculture Vaccines Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aquaculture Vaccines Market?

3. What are the technology trends and regulatory frameworks in the Aquaculture Vaccines Market?

4. What is the market share of the leading vendors in the Aquaculture Vaccines Market?

5. Which modes and strategic moves are suitable for entering the Aquaculture Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Aquaculture Vaccines Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the prevalence of bacterial and viral infections
      • 5.1.1.2. Increasing need for aquatic animal-derived food products
      • 5.1.1.3. Growing adoption of aquaculture vaccines over antibiotics
    • 5.1.2. Restraints
      • 5.1.2.1. Complex vaccine advancement processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancement and launch of new aquaculture vaccines
      • 5.1.3.2. Investment in R&D activities for the development of aquaculture vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory policies for vaccine approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Aquaculture Vaccines Market, by Type

  • 6.1. Introduction
  • 6.2. DNA Vaccines
  • 6.3. Inactivated Vaccines
  • 6.4. Live Attenuated Vaccines
  • 6.5. Sub-Unit Vaccines

7. Aquaculture Vaccines Market, by Product

  • 7.1. Introduction
  • 7.2. DNA Vaccines
  • 7.3. Inactivated Vaccines

8. Aquaculture Vaccines Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injected
  • 8.3. Oral

9. Aquaculture Vaccines Market, by Application

  • 9.1. Introduction
  • 9.2. Bacterial Diseases
  • 9.3. Viral Diseases

10. Aquaculture Vaccines Market, by End-User

  • 10.1. Introduction
  • 10.2. Aquaculture Farms
  • 10.3. Fisheries & Nurseries

11. Americas Aquaculture Vaccines Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Aquaculture Vaccines Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Aquaculture Vaccines Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. AniCon Labor GmbH by SAN Group
    • 15.1.2. Elanco
    • 15.1.3. Hipra, S.A.
    • 15.1.4. Indian Immunologicals Ltd.
    • 15.1.5. KBNP, Inc.
    • 15.1.6. Kyoto Biken Laboratories, Inc.
    • 15.1.7. Merck & Co., Inc.
    • 15.1.8. Nisseiken Co., Ltd.
    • 15.1.9. Pfizer Inc.
    • 15.1.10. Phibro Animal Health Corporation
    • 15.1.11. Vaxxinova International BV
    • 15.1.12. Virbac S.A.
    • 15.1.13. Zoetis Inc.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing